Literature DB >> 27191585

To Drug or Not to Drug: A Qualitative Study of Patients' Decision-Making Processes for Managing Insomnia.

Janet M Y Cheung1,2, Delwyn J Bartlett2, Carol L Armour3,4, Tracey-Lea Laba5, Bandana Saini1,2.   

Abstract

Treatment preferences play a key role in dictating sleep health outcomes. However, patients' treatment beliefs, attitudes, and experiences that inform preference conceptualization remain an unknown phenomenon. Therefore, this study aims to explore patient perceptions toward pharmacotherapy and the nonpharmacological management of insomnia. Fifty-one patients with insomnia were recruited from specialist clinics and general community settings. Participants completed a brief questionnaire followed by an in-depth semistructured interview that was digitally recorded, transcribed verbatim, and subjected to Framework Analysis to identify emergent themes. Three key themes were identified: Resolving Insomnia, Self-Imposed Treatment Boundaries, and Treatment Uptake. Patients' illness, treatment, and psychosocial beliefs and experiences are closely linked to treatment choice. Being attuned to these influences during the clinical encounter can facilitate treatment selection that is meaningful for the patient.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27191585     DOI: 10.1080/15402002.2016.1163702

Source DB:  PubMed          Journal:  Behav Sleep Med        ISSN: 1540-2002            Impact factor:   2.964


  12 in total

1.  Yonder: Breaking bad news, sleeping tablets, hysterectomy, and responsible officers.

Authors:  Ahmed Rashid
Journal:  Br J Gen Pract       Date:  2018-11       Impact factor: 5.386

2.  Who Is Seeking Help for Sleep? A Clinical Profile of Patients in a Sleep Psychology Clinic.

Authors:  Annie Vallières; Alric Pappathomas; Taís Araújo; Megan R Crawford; Séverine de Billy Garnier
Journal:  Int J Behav Med       Date:  2021-04

3.  Patient Preferences for Managing Insomnia: A Discrete Choice Experiment.

Authors:  Janet M Y Cheung; Delwyn J Bartlett; Carol L Armour; Bandana Saini; Tracey-Lea Laba
Journal:  Patient       Date:  2018-10       Impact factor: 3.883

4.  "You're Missing Out on Something Great": Patient and Provider Perspectives on Increasing the Use of Cognitive Behavioral Therapy for Insomnia.

Authors:  Erin Koffel; Erin Amundson; Grace Polusny; Jennifer P Wisdom
Journal:  Behav Sleep Med       Date:  2019-03-24       Impact factor: 2.964

5.  Pain-related beliefs about sleep as a predictor of insomnia symptoms and treatment acceptability.

Authors:  Scott G Ravyts; Elliottnell Perez; Joseph M Dzierzewski
Journal:  Sleep Med       Date:  2022-05-20       Impact factor: 4.842

6.  Insomnia Treatment Preferences Among Primary Care Patients.

Authors:  Elliottnell Perez; Emily K Donovan; Bruce D Rybarczyk; Joseph M Dzierzewski
Journal:  Clin Ther       Date:  2022-03-29       Impact factor: 3.637

Review 7.  Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review.

Authors:  Erin Koffel; Adam D Bramoweth; Christi S Ulmer
Journal:  J Gen Intern Med       Date:  2018-04-04       Impact factor: 5.128

8.  Patterns of concomitant prescription, over-the-counter and natural sleep aid use over a 12-month period: a population based study.

Authors:  Janet M Y Cheung; Denise C Jarrin; Simon Beaulieu-Bonneau; Hans Ivers; Geneviève Morin; Charles M Morin
Journal:  Sleep       Date:  2021-11-12       Impact factor: 6.313

9.  Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial.

Authors:  Anastasia Suraev; Ronald R Grunstein; Nathaniel S Marshall; Angela L D'Rozario; Christopher J Gordon; Delwyn J Bartlett; Keith Wong; Brendon J Yee; Ryan Vandrey; Chris Irwin; Jonathon C Arnold; Iain S McGregor; Camilla M Hoyos
Journal:  BMJ Open       Date:  2020-05-18       Impact factor: 2.692

Review 10.  Selecting a pharmacotherapy regimen for patients with chronic insomnia.

Authors:  Amanda B Hassinger; Nikolas Bletnisky; Rizwan Dudekula; Ali A El-Solh
Journal:  Expert Opin Pharmacother       Date:  2020-03-23       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.